Medications for Acute Myeloid Leukemia

26 results
  • Slate Run Pharmaceuticals, LLC
    Usage: Cyclophosphamide for Injection is indicated for treating various malignancies, including malignant lymphomas, multiple myeloma, leukemias, and solid tumors like breast cancer and ovarian adenocarcinoma. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome unresponsive to corticosteroid therapy.
  • Dr. Reddy's Laboratories Inc.
    Usage: Cyclophosphamide is indicated for treating malignant diseases in adults and pediatric patients, including various lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma. It is often used in combination with other antineoplastic agents.
  • Civica, Inc.
    Usage: Cyclophosphamide for Injection is indicated for treating various malignant diseases in adults and children, including malignant lymphomas, multiple myeloma, leukemias, and neuroblastoma. It is also used for pediatric patients with minimal change nephrotic syndrome who do not respond to or cannot tolerate corticosteroids.
  • Bamboo US BidCo LLC
    Usage: Cyclophosphamide is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, and certain solid tumors. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome who have not responded to corticosteroid therapy. Safety in adults for nephrotic syndrome is unestablished.
  • Bamboo US BidCo LLC
    Usage: Cyclophosphamide is indicated for treating various malignant diseases including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy is ineffective or intolerable.
  • NextSource Pharma
    Usage: Cyclophosphamide Capsules are indicated for treating various malignant diseases, including malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids.
  • Fresenius Kabi USA, LLC
    Usage: Cytarabine Injection is indicated for remission induction in acute non-lymphocytic leukemia in adults and pediatric patients, and for treating acute non-lymphocytic leukemia and blast phase chronic myelocytic leukemia. It is also used intrathecally for prophylaxis and treatment of meningeal leukemia.
  • Meitheal Pharmaceuticals Inc.
    Usage: Cytarabine Injection, in combination with other anti-cancer drugs, is indicated for remission induction in acute non-lymphocytic leukemia, acute lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia. It is also used intrathecally for prophylaxis and treatment of meningeal leukemia.
  • A-S Medication Solutions
    Usage: This drug is indicated for various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), dermatologic diseases (e.g., severe psoriasis), allergic conditions, and certain hematologic and gastrointestinal diseases. It can be administered via intravenous, intramuscular, intra-articular, or intralesional injection.
  • Henry Schein, Inc.
    Usage: This drug is indicated for various conditions such as endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), allergic states, dermatologic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, neoplastic diseases, and cerebral edema. It can be administered via injection or intra-articular methods.